Back
Karyopharm Therapeutics Stock Predictions
Sponsored
KPTI
Sponsored
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!
Sell
44
KPTI
Karyopharm Therapeutics
Last Price:
1.27
Seasonality Move:
-3.84%
7 Day Trial
ALL ACCESS PASS
$
7
I love this overnight trade happening Thursday
Access my free presentation on these overnight trades right hereKaryopharm Therapeutics Stock Forecast
-
Is Karyopharm Therapeutics Stock Undervalued?
The current Karyopharm Therapeutics [KPTI] share price is $1.28. The Score for KPTI is 44, which is 12% below its historic median score of 50, and infers higher risk than normal. - KPTI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Karyopharm Therapeutics Stock Go Up Next Year?
Data Unavailable
Karyopharm Therapeutics Stock Rating
Data Unavailable
Karyopharm Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
karyopharm.com
52-Week Data
52-Week High:
4.11
52-Week Low:
0.62
Prediction Charts
Market Cap:
146.71M
Price in USD:
1.28
Volume:
1.22M
Beta:
0.83
Technical Analysis
SMA50:
1.35
SMA100:
1.10
SMA200:
1.19
52-Wk Change:
-69.28%
Stock Predictions
-
Is Karyopharm Therapeutics stock public?
Yes, Karyopharm Therapeutics is a publicly traded company. -
What is the Karyopharm Therapeutics stock quote today?
The Karyopharm Therapeutics stock price is 1.28 USD today. -
How to buy Karyopharm Therapeutics stock online?
You can buy Karyopharm Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-1 | 1.51 | 1.59 | 1.65 | 1.45 |
Apr-2 | 1.55 | 1.40 | 1.56 | 1.38 |
Apr-3 | 1.39 | 1.28 | 1.39 | 1.28 |
Apr-4 | 1.29 | 1.33 | 1.44 | 1.25 |
Apr-5 | 1.31 | 1.36 | 1.41 | 1.28 |
Apr-8 | 1.38 | 1.35 | 1.39 | 1.29 |
Apr-9 | 1.33 | 1.34 | 1.41 | 1.31 |
Apr-10 | 1.31 | 1.26 | 1.34 | 1.25 |
Apr-11 | 1.28 | 1.33 | 1.34 | 1.26 |
Apr-12 | 1.34 | 1.22 | 1.35 | 1.18 |
Apr-15 | 1.22 | 1.15 | 1.23 | 1.14 |
Apr-16 | 1.14 | 1.09 | 1.20 | 1.03 |
Apr-17 | 1.19 | 1.38 | 1.38 | 1.14 |
Apr-18 | 1.42 | 1.28 | 1.42 | 1.22 |
Karyopharm Therapeutics Earnings
Data Unavailable
Karyopharm Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.07 per share, a decrease this year of $0.02 per share, and an increase next year of $0.20 per share.
* Karyopharm Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.